A Study On Potential Drug Target For SARS-CoV-2-And Combinatorial Therapeutic Approach To Combat COVID-19
Article Sidebar
Main Article Content
Abstract
The COVID-19 pandemic caused by (SARS-CoV-2) a threat, leading to numerous deaths and socioeconomic disruptions. Spurred intense research efforts effective treatment. Our study provides a brief overview COVID-19. Urgent need for effective treatments has prompted extensive research to identify potential drug targets against disease. Review shows most promising drug and their associated therapeutic approaches for combating COVID-19. Key targets include the spike protein, which facilitates viral entry into host cells, and proteases essential for viral replication. Additionally, RNA-dependent RNA polymerase (RdRp) inhibitors have been explored to inhibit viral RNA replication, highlighting their mechanisms of action, potential therapeutic benefits, and challenges in drug development. Host factors, such as the ACE2 receptor and immune response modulators, are also targeted. Combination therapies and overcoming challenges in the drug development are crucial for successful COVID-19 treatment. In this review the molecular docking study is discussed here. The future perspective of drug targets for COVID-19 encompasses a range of innovative approaches aimed at combating the virus and preparing for future outbreaks. The review also discusses the challenges faced and future directions in the field of drug target research for COVID-19. This review will provide an overview of the anticipated advancements in drug target discovery and development for COVID-19, highlighting key areas of focus and potential strategies.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
Abomughaid, M.; Nofal, M. S.; Ghaleb, K. I.; Seadawy, M. G.; Wahab, M. G. A.; Hegazy, A. S.; Ghareeb, D. A.; (2022); ZnO-chlorogenic acid nanostructured complex inhibits Covid-19 pathogenesis and increases hydroxychloroquine efficacy; Journal of King Saud University - Science; 34(8):102296; https://doi.org/10.1016/j.jksus.2022.102296
AbouAitah, K.; Allayh, A. K.; Wojnarowicz, J.; Shaker, Y. M.; Sroda, A. S. and Lojkowski, W.; (2021); Nanoformulation Composed of Ellagic Acid and Functionalized Zinc Oxide Nanoparticles Inactivates DNA and RNA Viruses; Pharmaceutics; 13(12); 2174; https://doi.org/10.3390/pharmaceutics13122174
Adem, Ş.; Eyupoglu, V.; Sarfraz, I.; Rasul, A.; Zahoor, A. F.; Ali, M.; Abdalla, M.; Ibrahim, I. M.; Elfiky, A. A.; (2021); Caffeic acid derivatives (CAFDs) as inhibitors of SARS-CoV-2: CAFDs-based functional foods as a potential alternative approach to combat COVID-19; Phytomedicine; 85:153310; https://doi.org/10.1016/j.phymed.2020.153310
Avula, B.; Katragunta, K.; Wang, Y. H.; Ali, Z.; Khan, I. A.; (2022); Simultaneous determination and characterization of flavonoids, sesquiterpene lactone, and other phenolics from Centaurea benedicta and dietary supplements using UHPLC-PDA-MS and LC-DAD-QToF; Journal of Pharmaceutical and Biomedical Analysis; 216:114806; https://doi.org/10.1016/j.jpba.2022.114806
Chang, R.; Sun, W. Z.; (2020); Repositioning chloroquine as antiviral prophylaxis against COVID-19: potential and challenges; Drug Discovery Today; 25(10); 1786-1792;
https://doi.org/10.1016/j.drudis.2020.06.030
Deng, Y.; Ma, J.; Weng, X.; Wang, Y.; Li, M.; Yang, T.; Dou, Z.; Yin, Z. and Shang, J.; (2021); Kaempferol-3-O-Glucuronide Ameliorates Non-Alcoholic Steatohepatitis in High-Cholesterol-Diet-Induced Larval Zebrafish and HepG2 Cell Models via Regulating Oxidation Stress; Life; 11(5); 445; https://doi.org/10.3390/life11050445
Dhanjal, J. K.; Kumar, V.; Garg, S.; Subramani, C.; Agarwal, S.; Wang, J.; Zhang, H.; Kaul, A.; Kalra, R. S.; Kaul, S. C.; Vrati, S.; Sundar, D. and Wadhwac, R.; (2021); Molecular mechanism of anti-SARS-CoV2 activity of Ashwagandha-derived withanolides; Int J Biol Macromol.; 184: 297–312; doi: 10.1016/j.ijbiomac.2021.06.015
Di Matteo, G.; Spano, M.; Grosso, M.; Salvo, A.; Ingallina, C.; Russo, M.; Ritieni, A. and Mannina, L.; (2020); Food and COVID-19: Preventive/Co-therapeutic Strategies Explored by Current Clinical Trials and in Silico Studies; Foods; 9(8); 1036; https://doi.org/10.3390/foods9081036
Diniz, L. R. L.; Elshabrawy, H. A.; Souza, M. T. S.; Duarte, A. B. S.; Datta, S. and de Sousa, D. P.; (2021); Catechins: Therapeutic Perspectives in COVID-19-Associated Acute Kidney Injury; Molecules.; 26(19):5951; doi: 10.3390/molecules26195951
Hossain, M. A.; Sohel, M.; Sultana, T.; Hasan, M. I.; Khan, M. S.; Kibria, K. M. K.; Mahmud, S. M. H.; Rahman, M. H.; (2023); Study of kaempferol in the treatment of COVID-19 combined with Chikungunya co-infection by network pharmacology and molecular docking technology; Informatics in Medicine Unlocked; 40:101289; https://doi.org/10.1016/j.imu.2023.101289
Hossain, R.; Mahmud, S.; Khalipha, A. B. R.; Saikat, A. S. M.; Dey, D.; Khan, R. A.; Rauf, A.; Wadood, A.; Rafique, H.; Bawazeer, S.; Khalil, A. A.; Almarhoon, Z. M.; Mabkhot, Y. N.; Alzahrani, K. J.; Islam, M. T.; Alsharif, K. F.; Khan, H.; (2023); Amentoflavone derivatives against SARS-CoV-2 main protease (MPRO): An in silico study; Journal: Main Group Chemistry; 22(2); 313-327; DOI: 10.3233/MGC-220077
Imran, M.; Thabet, H. K.; Alaqel, S. I.; Alzahrani, A. R.; Abida, A.; Alshammari, M. K.; Kamal, M.; Diwan, A,; Asdaq, S. M. B. and Alshehri, S.; (2022); The Therapeutic and Prophylactic Potential of Quercetin against COVID-19: An Outlook on the Clinical Studies, Inventive Compositions, and Patent Literature; Antioxidants; 11(5); 876; https://doi.org/10.3390/antiox11050876
Kim, S.; Hong, K. B.; Jo, K. and Suh, H. J.; (2021); Quercetin-3-O-glucuronide in the Ethanol Extract of Lotus Leaf (Nelumbo nucifera) Enhances Sleep Quantity and Quality in a Rodent Model via a GABAergic Mechanism; Molecules; 26(10); 3023; https://doi.org/10.3390/molecules26103023
Kim, Y. S.; Kim, B.; Kwon, E. B.; Chung, H. S. and Choi, J. G.; (2022); Mulberrofuran G, a Mulberry Component, Prevents SARS-CoV-2 Infection by Blocking the Interaction between SARS-CoV-2 Spike Protein S1 Receptor-Binding Domain and Human Angiotensin-Converting Enzyme 2 Receptor; Nutrients.; 14(19):4170; doi: 10.3390/nu14194170
Kim, Y. S.; Kwon, E. B.; Kim, B.; Chung, H. S.; Choi, G.; Kim, Y. H. and Choi, J. G.; (2022); Mulberry Component Kuwanon C Exerts Potent Therapeutic Efficacy In Vitro against COVID-19 by Blocking the SARS-CoV-2 Spike S1 RBD:ACE2 Receptor Interaction; Int. J. Mol.; 23(20); 12516;
https://doi.org/10.3390/ijms232012516
Kimura, H.; Kurusu, H.; Sada, M.; Kurai, D.; Murakami, K.; Kamitani, W.; Tomita, H.; Katayama, K.; Ryo, A.; (2020); Molecular pharmacology of ciclesonide against SARS-CoV-2; The Journal of Allergy and Clinical Immunology; 146(2); https://doi.org/10.1016/j.jaci.2020.05.029
Kuboyama, T.; Tohda, C.; Komatsu, K.; (2006); Withanoside IV and its active metabolite, sominone, attenuate Aβ(25–35)-induced neurodegeneration; European Journal of Neuroscience; 23(6):1417-26; https://doi.org/10.1111/j.1460-9568.2006.04664.x
Li, J.; Xiang, H.; Huang, C.; Lu, J.; (2021); Pharmacological Actions of Myricetin in the Nervous System: A Comprehensive Review of Preclinical Studies in Animals and Cell Models; Front. Pharmacol.; 12; https://doi.org/10.3389/fphar.2021.797298
Li, J.; Xu, D.; Wang, L.; Zhang, M.; Zhang, G.; Li, E. and He, S.; (2021); Glycyrrhizic Acid Inhibits SARS-CoV-2 Infection by Blocking Spike Protein-Mediated Cell Attachment; Molecules; 26(20):6090; https://doi.org/10.3390/molecules26206090
Maciorowski, D.; Idrissi, S. Z. E.; Gupta, Y.; Medernach, B. J.; Burns, M. B.; Becker, D. P.; Durvasula, R.; Kempaiah, P.; (2020); A Review of the Preclinical and Clinical Efficacy of Remdesivir, Hydroxychloroquine, and Lopinavir-Ritonavir Treatments against COVID-19; SLAS Discovery; 25(10); https://doi.org/10.1177/2472555220958385
Malin, J. J.; Suárez, I.; Priesner, V.; Fätkenheuer, G.; Rybniker, J.; (2020); Remdesivir against COVID-19 and Other Viral Diseases; Clinical Microbiology Reviews; 34(1); https://doi.org/10.1128/cmr.00162-20
Meeran, M. F. N.; Seenipandi, A.; Javed, H.; Sharma, C.; Hashiesh, H. M.; Goyal, S. N.; Jha, N. K.; Ojha, S.; (2021); Can limonene be a possible candidate for evaluation as an agent or adjuvant against infection, immunity, and inflammation in COVID-19?; Heliyon; 7(1):e05703;
https://doi.org/10.1016/j.heliyon.2020.e05703
Okamoto, S.; Ishihara, S.; Okamoto, T.; Doi, S.; Harui, K.; Higashino, Y.; Kawasaki, T.; Nakajima, N. and Saito, A.; (2014); Inhibitory Activity of Synthesized Acetylated Procyanidin B1 Analogs against HeLa S3 Cells Proliferation; Molecules; 19(2); 1775-1785; https://doi.org/10.3390/molecules19021775
Pasquereau, S.; Galais, M.; Bellefroid, M.; Angona, I. P.; Bizot, S. M.; Ismaili, L.; Lint, C. V. & Herbein, G.; (2022); Ferulic acid derivatives block coronaviruses HCoV-229E and SARS-CoV-2 replication in vitro; Sci Rep; 12:20309; https://doi.org/10.1038/s41598-022-24682-9
Rafiq, A.; Jabeen, T.; Aslam, S.; Ahmad, M.; Ashfaq, U. A.; Mohsin, N. A.; Zaki, M. E. A. and Al-Hussain, S. A.; (2023); A Comprehensive Update of Various Attempts by Medicinal Chemists to Combat COVID-19 through Natural Products; Molecules; 28(12); 4860; https://doi.org/10.3390/molecules28124860
Rizzuti, B.; Grande, F.; Conforti, F.; Alesanco, A. J.; Laita, L. C.; Alarcon, D. O.; Vega, S.; Reyburn, H. T.; Abian, O. and Campoy, A. V.; (2021); Rutin Is a Low Micromolar Inhibitor of SARS-CoV-2 Main Protease 3CLpro: Implications for Drug Design of Quercetin Analogs; Biomedicines.; 9(4):375; doi: 10.3390/biomedicines9040375
Salehi, B.; Fokou, P. V. T.; Rad, M. S.; Zucca, P.; Pezzani, R.; Martins, N. and Rad, J. S.; (2019); The Therapeutic Potential of Naringenin: A Review of Clinical Trials; Pharmaceuticals (Basel).; 12(1):11; doi: 10.3390/ph12010011
Sánchez, R. P.; Fragoso, J. M.; Muñoz, F. S.; Velasco, G. R.; Bello, J. R.; Reyes, A. L.; Gómez, L. E. M.; Fernández, C. S.; Reyna, T. R.; Zamarripa, N. E. R.; Martínez, G. R.; Ramos, J. Z. and Alarcón, G. V.; (2022); Association of the Transmembrane Serine Protease-2 (TMPRSS2) Polymorphisms with COVID-19; Viruses; 14(9); 1976; https://doi.org/10.3390/v14091976
Semmarath, W.; Mapoung, S.; Umsumarng, S.; Arjsri, P.; Srisawad, K.; Thippraphan, P.; Yodkeeree, S. and Dejkriengkraikul, P.; (2022); Cyanidin-3-O-glucoside and Peonidin-3-O-glucoside-Rich Fraction of Black Rice Germ and Bran Suppresses Inflammatory Responses from SARS-CoV-2 Spike Glycoprotein S1-Induction In Vitro in A549 Lung Cells and THP-1 Macrophages via Inhibition of the NLRP3 Inflammasome Pathway; Nutrients; 14(13):2738;https://doi.org/10.3390/nu14132738
Singh, S.; Weiss, A.; Goodman, J.; Fisk, M.; Kulkarni, S.; Lu, I.; Gray, J.; Smith, R.; Sommer, M.; Cheriyan, J.; (2022); Niclosamide—A promising treatment for COVID-19; British Journal of Pharmacology; 179(13); 3250-3267; https://doi.org/10.1111/bph.15843
Souid, I.; Korchef, A.; Souid, S.; (2022); In silico evaluation of Vitis amurensis Rupr. Polyphenol compounds for their inhibition potency against COVID-19 main enzymes Mpro and RdRp; Saudi Pharmaceutical Journal; 30(5); 570-584; https://doi.org/10.1016/j.jsps.2022.02.014
Speciale, A.; Muscarà, C.; Molonia, M. S.; Cimino, F.; Saija, A.; Giofrè, S. V.; (2021); Silibinin as potential tool against SARS-Cov-2: In silico spike receptor-binding domain and main protease molecular docking analysis, and in vitro endothelial protective effects; Phytotherapy Research; 35(8); 4616-4625; https://doi.org/10.1002/ptr.7107
Uckun, F. M.; Saund, S.; Windlass, H.; Trieu, V.; (2021); Repurposing Anti-Malaria Phytomedicine Artemisinin as a COVID-19 Drug; Front. Pharmacol.; 12:649532;
https://doi.org/10.3389/fphar.2021.649532
Umar, H. I.; Siraj, B.; Ajayi, A.; Jimoh, T. O. and Chukwuemeka, P. O.; (2021); Molecular docking studies of some selected gallic acid derivatives against five non-structural proteins of novel coronavirus; J Genet Eng Biotechnol.; 19:16; doi: 10.1186/s43141-021-00120-7
Vardhan, S. and Sahoo, S. K.; (2022); Computational studies on the interaction of SARS-CoV-2 Omicron SGp RBD with human receptor ACE2, limonin and glycyrrhizic acid; Computers in Biology and Medicine; 144:105367; doi: 10.1016/j.compbiomed.2022.105367
Wang, Y.; Tang, C.; Zhang, H.; (2015); Hepatoprotective effects of kaempferol 3-O-rutinoside and kaempferol 3-O-glucoside from Carthamus tinctorius L. on CCl4-induced oxidative liver injury in mice; Journal of Food and Drug Analysis; 23(2); 310-317; https://doi.org/10.1016/j.jfda.2014.10.002
Wang, Y.; Wu, S.; Li, Q; Lang, W.; Li, W.; Jiang, X.; Wan, Z.; Chen, J.; Wang, H.; (2022); Epigallocatechin-3-gallate: A phytochemical as a promising drug candidate for the treatment of Parkinson’s disease; Front. Pharmacol.; 13; https://doi.org/10.3389/fphar.2022.977521
Zhang, X. Y.; Huang, H. J.; Zhuang, D. L.; Nasser, M. I.; Yang, M. H.; Zhu, P. & Zhao, M. Y.; (2020); Biological, clinical and epidemiological features of COVID-19, SARS and MERS and AutoDock simulation of ACE2; Infectious Diseases of Poverty; 9(99); https://doi.org/10.1186/s40249-020-00691-6